Obesity and Preeclampsia: Common Pathophysiological Mechanisms

Area of Science:

• Obstetrics and Gynecology
• Cardiovascular Disease Research
• Nutritional Science

Background:

• Preeclampsia is a pregnancy disorder (after 20 weeks) marked by new hypertension and proteinuria.
• Early signs include abnormal placentation and impaired trophoblast invasion.
• Obesity, overweight, and nutritional deficits are linked to preeclampsia development and severity.

Purpose of the Study:

• To explore the interrelationship between maternal obesity/overweight and preeclampsia.
• To review common underlying mechanisms linking obesity, preeclampsia, and cardiovascular disease.
• To highlight the L-arginine/nitric oxide pathway as a key shared mechanism.

Main Methods:

• Review of studies on populations with obesity and preeclampsia.
• Analysis of mechanisms connecting obesity, preeclampsia, and cardiovascular outcomes.
• Focus on the L-arginine/nitric oxide pathway alterations.

Main Results:

• Studies confirm a significant association between maternal overweight/obesity and preeclampsia.
• Obesity and preeclampsia share pathways including hyperinsulinism, insulin resistance, and systemic inflammation.
• The L-arginine/nitric oxide pathway dysfunction is a common link.

Conclusions:

• Maternal obesity and overweight are significant risk factors for preeclampsia.
• Shared pathophysiological mechanisms, particularly the L-arginine/nitric oxide pathway, connect obesity, preeclampsia, and future cardiovascular risk.
• Understanding these links is crucial for maternal and long-term health management.